What Asia’s scramble for mRNA production facilities means for the future of vaccine manufacturing in the region

Since the arrival of Pfizer and Moderna’s mRNA vaccines for Covid-19, Asia-Pacific countries have struggled to source adequate supplies.Governments including those of Australia, South Korea and Singapore are now racing to establish facilities to manufacture the jabs themselves – and in the process harness a potentially game-changing technology in the fight against disease.For countries that did not secure abundant vaccine supplies early on, the moves are unlikely to boost their sluggish…

Read the original article at South China Morning Post